Clinical Trial Update: An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating Me-4FDG PET/CT as an investigational imaging tracer for early detection of lung adenocarcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Me-4FDG PET/CT tracer (Me-4FDG)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING